Goals of antibacterial treatment
disrupt/prevent bacterial infection without affecting the host too much
kill micro bacteria
Ideal drug
not toxic to host cell
relatively soluble
does not lead to antimicrobial resistance
Three factors needed to be known before therapy
identity of microorganism
how susceptible is the the microorganism to drugs
what is the condition of the person infected?
Methods for testing antimicrobial susceptibility
Disc diffusion test/ Kirby-Bauer, tube dilution test
Disc diffusion/ Kirby-Bauer test
looks at region of bacteria diffusion into media, small discs of antibacterial put onto medium, once incubated the "zone of inhibition" surround the disc is measured and compared with a standard of each drug
Tube dilution test
antimicrobial is diluted serially in tubes of broth and inoculated with a pure culture, once incubated it is examined for growth
Minimum Inhibitory Concentration
the smallest concentration (highest dilution) of a drug that visibly inhibits growth
Therapeutic Index
ratio of the dose of the drug that is toxic to humans compared to its minimum effective dose ------> the smaller the ration the greater for potential toxic drug reactions ------> drug with highest TI has the widest margin of safety
Failure of Antimicrobial treatment due to
Delivery of drug (able to reach target site)
resistance
what if it is polymicrobial?
consistent with treatment
Goal of antimicrobial drugs
Disrupting, inhibit
interfere
destroy
selectively toxic
Broad Spectrum drugs
drugs that target a wide range of microbes
Narrow Spectrum drugs
drugs that target a small range/few microbes
Drug classifications
targets cell wall
targets protein synthesis
targets folic acid synthesis
target cytoplasmic or cell membrane
Drugs that target cell wall
penicillin, cephalusporins
Drugs that target protein synthesis
2 types: aminoglycosides, tetracyclines
Aminoglycosides
insert on sites on the 30S subunit and cause the misreading of mRNA, leads to abnormal proteins
Tetracyclines
block the attachment of tRNA on the A acceptor site and stop further protein synthesis
Drugs that target folic acid synthesis
sulfonamides
Sulfonamides
interferes with folate metabolism by blocking ezymes
Drugs that target cell membrane
polymyxins
Polymyxins
interact with membrane phospholipids to break them down
Biofilm treatment strategies
interrupting quorum sensing pathways
adding DNAse to antibiotic acids penetration through extracellular debris
interpreting devices with antibiotics prior to implantation
Some antibiotics cause:
biofilms to form at a higher rate than they normally would
Vaccines prevent
measles, mumps, hepatitus
Virus diseases that need more effective medication s
aids, influenza, common cold
Drug resistance
an adaptive response in which microorganisms begin to tolerate an amount of drug that would normally be inhibited
microbes become resistant to a drug after
spontaneous mutations in critical chromosomal genes
acquisition of entire new genes or sets of genes via horizontal transfer from another species
Mechanisms of drug resistance
targets the drug: production of lactum ring inactivates penicillin
alters its target/shape so antibiotic cannot recognize it
efflux pumps: pumps drugs out of bacteria
change in enzymatic pathway
Probiotics
preparations of live micro-bacterium fed to animals and humans to improve intestinal biota
Prebiotic
nutrients that encourage growth of beneficial microbes of the intestine
Fecal transplant
treats reoccurent clostridiods difficile infection and ulcerative colitis; transfers feces from healthy via colonoscopy
Colonization
resident microbiota
Infection
microbes get past barrier
Disease
deviation from health
Infectious disease
pathogenic state
Contamination
excessive amount of growth
Pathogen
a microbe whose relationship is with its host parasitic and results in infection and disease
Pathogenicity
an organism's potential to cause disease
True pathogens
capable of causing a disease in a healthy organism
Opportunistic pathogens
has potential to cause harm but relies on compromised immune system
Virulence
relatively severity of disease by a particular microbe; degree of pathogenicity
Virulence factor determined by:
establish
cause
Virulence factor
a microbes structures or capabilities that allow it to establish itself in a host and cause damage
Polymicrobial Infections
majority of infections are polymicrobial with contributions from more than one microbe
Exogenous
microbe introduced from outside
Endogenous
microbe introduced from inside
Steps to becoming established
portal of Entry
attaching to host cell
surviving host defense
causing disease
Vacating the host- portals of exit
Portal of entry
the route that a microbe takes to enter the tissues of the body to initiate an infection
pathogens specifically adapted to specific portal of entry but pathogens can enter more than one portal
Infectious dose
the minimum number of microbes necessary to cause an infection to proceed; microorganisms with smaller infectious doses have greater virulence
attaching to the host cell
Adhesion: process by which microbes gain a more stable foothold on host tissues
Causing disease
three ways: directly, indirectly, epigenetic changes
Directly
actin of exoenzymes, toxins
Exoenzymes
enzymes secreted by microbe that break down and inflict damages on tissues; dissolves the hosts defense barriers to promote the spread of disease to the other tissue
Toxins
a specific chemical product of microbes that is poisonous to other organisms
Toxin types
Neurotoxins: act on nervous system Enterotoxins: act on intestine Hemotoxins: lyse red blood cells Nephrotoxins: damage to kidney Endotoxins Exotoxins
Indirectly
inducing the hosts defense (immune response)
Epigenetic changes
environmental changes that changes the way the genes work
Distribution of pathogen
localized infection, systemic infection
Localized infection
microbe limited to small area
Systemic infection
agent spread throughout the body
Causing Disease warning signals
sign symptom syndrome
Sign
objective evidence of disease as noted by an observer
Symptom
subjective evidence of disease as sensed by the patient
Syndrome
a disease identified by a certain complex of signals and symptoms
Portal of exit
specific venue by which pathogens exit; shed through secretion, excretion, discharge, or sloughed tissue
Major portals of exit
coughing, sneezing insect bite skin cells open lesions urine feces removal of blood
Stages of infection and disease
incubation period prodromal stage acute phase convalescent period continuation period
Incubation period
the period from the initial contact with an infectious agent to the appearance of the first symptoms
Prodromal stage
a short period incubation; indicates onset of disease
Acute phase
specific signs and symptoms are seen and pathogen is at peak activity
Convalescent period
phase which either the organism linger after symptoms subside or the symptoms continue after the organism is no longer detectable
Reservoir
primary habitat in the natural world from which a pathogen originates
Transmitter
indiviual or object from which an infection is acquired
Vertical transmission
transmission if ro parent to offspring via the ovum, sperm, or milk
Horizontal transmission
disease is spread through a population from one infected indiviual to another; 3 types
3 types of horizontal transmission
direct transmission indirect transmission vector transmission
Formite
form of indirect transmission from an inanimate object
Vehicle
form of indirect transmission from natural non-living material like air, water, soil, and food
HAI
infectious diseases acquired or developed during a hospital or health car facility stay
Factors tied to HAI
patients collection points lowered defenses acquisition
Successful identification and treatment relies on
asceptic
sterile
Asceptic
free from contamination caused by harmful bacteria, viruses, and other
Phenotypic methods
observing traits an organism is expressing, examining microbe appearance and behavior, immediate direct examination of the specimen
Phenotypic examination
enzymatic activities physical conditions antibiotics chemical composition
Phenotypic method that does not require cultivation
direct examination
Direct examination
microscopy of patient specimens (after staining)
Phenotypic method that requires cultivation
selective/differential growth biochemical testing susceptibility testing Phage typing
Selective/differential growth
identifies characteristics such as colony, appearance, motility, gas requirements
Biochemical testing
growth detects the prescence of microbes of enzymes, creating metabolic fingerprint
Susceptibility testing
detects a pattern of antimicrobial susceptibility to identify microbe; useful in determining what drugs will be used for treatment, used during pathogen identification
Phage typing
testing bacterial sensitivity to phages by determining its lyse
Phenotypic method drawbacks 1
it has to be cultured
Phenotypic method drawbacks 2
multiple infections
Phenotypic method drawbacks 3
non-culture
Phenotypic method drawbacks 4
easy misidentify: can go undetected
Phenotypic method drawbacks 5
takes longer
Dichotomous key
flowchart leading to identification; combines results of gram staining, growth on differential media, and enzymatic testing
Sensitivity
high, low; the levels you can detect and their variations
Specificity
the ability to target one specific target and that one only
Immunological methods
involves in vitro testing serum, urine, cerebrospinal fluid, whole tissues, and saliva for the presence of specific antibodies